These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26803577)

  • 1. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.
    Nasr G; Cristian A; Barboiu M; Vullo D; Winum JY; Supuran CT
    Bioorg Med Chem; 2014 May; 22(10):2867-74. PubMed ID: 24746465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties.
    Singasane N; Kharkar PS; Ceruso M; Supuran CT; Toraskar MP
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):901-7. PubMed ID: 25744513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
    Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
    Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT
    Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
    Bozdag M; Alafeefy AM; Vullo D; Carta F; Dedeoglu N; Al-Tamimi AM; Al-Jaber NA; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2015 Dec; 23(24):7751-64. PubMed ID: 26639945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
    Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT
    Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds.
    Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds.
    Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.